Clinical Trial

Sunvozertinib Treatment in Untreated Advanced NSCLC With EGFR Uncommon Mutations

Name: Sunvozertinib Treatment in Untreated Advanced NSCLC With EGFR Uncommon Mutations — clinical trial record (NCT07117890)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: WU-KONG35

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study is a single arm study to access the anti-tumor efficacy and safety of sunvozertinib in untreated advanced NSCLC patients with EGFR uncommon mutations.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-08-05.

Trial Details

NCT Number	NCT07117890
Lead Sponsor	Fudan University
Conditions	Non Small Cell Lung Cancer
Enrollment	34 participants
Start Date	2025-02-07
Primary Completion	2027-02-20 (estimated)
Study Completion	2027-05-30 (estimated)
Updated on ClinicalTrials.gov	2025-12-24